Amgevita
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Amgevita, covering 2026-04-23 to 2026-08-18. Get the full timeline:
Most recent: EMA Authorised: Amgevita (adalimumab) — Amgen Europe B.V.
2 regulatory and trial events tracked for Amgevita, covering 2026-04-23 to 2026-08-18. Get the full timeline:
Most recent: EMA Authorised: Amgevita (adalimumab) — Amgen Europe B.V.